Apyx Medical Corporation (APYX)
APYXNASDAQ-GSMedical/Dental Instruments
$2.96
+0.0200 (+0.68%) today
Regular session, Nov 10, 1:06 PM ET
- Market cap
- $124.70m
- P/E
- –
- EPS, last 4 quarters
- $-0.1900
- Dividend yield
- –
- Day range
- $2.88 to $3.02
- 52-week range
- $2.25 to $5.08
- Average volume
- 138.9k
- Previous close
- $2.94
Analysts
3 coveringBuy3 buy, 0 hold, 0 sell
Targets a year out average $6.33, +113.9% from here
Earnings
next estimate $-0.0400Next report
Dec 2025
+50.0%
Mar 2026
+54.5%
Jun 2026
-16.7%
Sep 2026
+42.9%
estimate reported, and the surprise
Financials
| Quarter | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | $12.88m | $19.16m | $12.49m | $13.88m |
| Gross profit | $8.30m | $12.00m | $7.92m | $8.87m |
| Operating income | -$832.0k | $11.0k | -$911.0k | -$1.81m |
| Net income | -$1.98m | -$1.30m | -$2.11m | -$3.24m |
Last four quarters: revenue $58.41m, margin -14.8%, free cash flow -$11.05m
News
8 latest- Apyx Medical Corporation Reports Third Quarter 2026 Financial ResultsFintel · 5 days ago
- Apyx Medical (APYX) Q3 2026 Earnings Call TranscriptThe Motley Fool · 5 days ago
- Apyx Medical Q3 Earnings Call HighlightsMarketBeat · 5 days ago
- Apyx Medical (APYX) Reports Q3 Loss, Tops Revenue EstimatesZacks · 5 days ago
- Evolus, Inc. (EOLS) Reports Q3 Loss, Beats Revenue EstimatesZacks · 6 days ago
- Maxim Group Initiates Coverage of Apyx Medical with BuyFintel · Sep 29, 2026
- Apyx Medical (APYX) Q2 2026 Earnings Call TranscriptThe Motley Fool · Aug 13, 2026
- Apyx Medical Sees GLP-1 Boom Fueling Demand for Renuvion, AYON Body ContouringMarketBeat · Aug 11, 2026
The company
Apyx Medical Corporation is a surgical aesthetics company with a passion for elevating people's lives through innovative products including its Helium Plasma Platform Technology products marketed and sold as Renuvion, the AYON Body Contouring SystemTM in the cosmetic surgery market and J-Plasma in the hospital surgical market. Renuvion and J-Plasma offer surgeons a unique ability to provide controlled heat to tissue to achieve their desired results. The effectiveness of Renuvion and J-Plasma are supported by more than 90 clinical documents. The AYON Body Contouring System is an FDA-cleared, groundbreaking, surgeon-designed body contouring system that combines precision, versatility and innovation in an all-in-one platform. It seamlessly integrates fat removal, closed loop contouring, electrosurgical capabilities and Renuvion for tissue contraction, empowering surgeons to deliver the most comprehensive body contouring treatments for patients.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Exchange
- NASDAQ-GS
- Region
- North America
- Website
- apyxmedical.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.